51. Subcellular fractionation of murine erythroleukaemic cells: localisation of protein kinases. The 30th Annual Congress of the South African Society of Pathologists. Cape Town. July 1990.
52. Phosphoamino acid phosphatases of human placental tissue. The 30th Annual Congress of the South African Society of Pathologists. Cape Town. July 1990.
53. Phosphorylation of endogenous proteins in primate kidney : effect of cyclic AMP. Renal Society Annual Congress. Johannesburg. August 1990.
54. Glucocorticoid binding and protein kinase C activity in murine erythroleukaemic cells. The 15th International Cancer Congress. Hamburg, Germany. August 1990.
55. Phosphorylation and dephosphorylation of proteins in breast cancer cells. Third European Congress on Cell Biology. Florence, Italy. September 1990.
56. Expression of G-proteins in murine erythroleukaemic cells. Tenth Congress of the South African Biochemical Society, Pietermaritzburg. January 1991. p85.
57. Evaluation of messenger RNA for src in proliferating and differentiating MEL cells. Tenth Congress of the South African Biochemical Society. Pietermaritzburg. January 1991. p99.
58. Subcellular distribution of protein kinase C in relation to HMBA-induced differentiation in murine erythroleukaemic cells. Tenth Congress of the South African Biochemical Society. Pietermaritzburg. January 1991. p101.
59. Protein kinase C and the reversible phosphorylation of proteins in human leukocytes. Tenth Congress of the South African Biochemical Society. Pietermaritzburg. January 199 1. p106.
60. Endogenous protein phosphorylation in primate kidney cortex: effects of modulators of the calcium messenger system. Tenth Congress of the South African Biochemical Society. Pietermaritzburg. January 1991. p 115.
61. Effects of the tumour promoter okadaic acid on protein phosphorylation in human lymphocytes. The 31st Annual Congress of the Federation of South African Societies of Pathology, Warmbaths, July 1991, CP7.
62. Subcellular distribution of calcium/phospholipid dependent and independent protein kinase C in murine erythroleukaemic cells. The 31st Annual Congress of the Federation of South African Societies of Pathology. Warmbaths. July 1991. CP8.
63. Protein phosphorylation and protein kinase C in normal and cancerous human tissues. The 31st Annual Congress of the Federation of South African Societies of Pathology. Warmbaths. July 1991. CP9.
64. Tyrosine phosphorylation associated with murine erythroleukaemic cell differentiation and glucocorticoid receptor binding. The 31st Annual Congress of the Federation of South African Societies of Pathology. Warmbaths. July 1991. CP10.
65. A continuous assay for phosphotyrosine phosphatase: oscillations in the activity in murine erythroleukaemia cells. The 31st Annual Congress of the Federation of South African Societies of Pathology. Warmbaths. July 1991. CP11.
66. Intracellular signalling via oscillatory processes: action of agents on enzyme and isoenzyme rhythms. The 8th International Conference on Second Messengers and Phosphoproteins. Scotland 1992. T139F.
67. Expression of the ras oncogene and its protein product in murine erythroleukaemic cells. The 8th International Conference on Second Messengers and Phosphoproteins. Scotland 1992. MI9SW.
68. Protein kinase C in normal and leukaemic human lymphocytes. The 32nd Annual Congress of the Federation of South African Societies of Pathology. June 1992. CP4.
69. Phosphorylation dynamics in relation to induced differentiation, mitogenesis and the reversal of malignancy. The 32nd Annual Congress of the Federation of South African Societies of Pathology. Wild Coas., June 1992. CP5.
70. Phosphorylation patterns in placenta. The 32nd Annual Congress of the Federation of South African Societies of Pathology, Wild Coast. June 1992. CP6.
71. Tyrosine phosphorylation and the GAP protein in proliferating and differentiating cells. The 32nd Annual Congress of the Federation of South African Societies of Pathology. Wild Coast. June 1992. CP7.
72. Protein kinase C substrates, activity and isoenzyme patterns in human placenta. The 33rd Annual Congress of the Federation of South African Societies of Pathology. Sun City. August 1993. P68.
73. Oscillations in phosphorylation processes in murine erythroleukaemic cells: insulin stimulation of the dynamics. The 33rd Annual Congress of the Federation of South African Societies of Pathology. Sun City. August 1993. P69.
74. Platelet-derived growth factor in human breast tissue. The 33rd Annual Congress of the Federation of South African Societies of Pathology. Sun City. August 1993. P71.
75. The effects of epidermal growth factor on tyrosine phosphorylation and the expression of the GAP protein in MEL and HL60 cells. The 33rd Annual Congress of the Federation of South African Societies of Pathology. Sun City. August 1993. P72.
76. Expression of the p53 tumour suppressor protein in proliferating and differentiating cells. The 33rd Annual Congress of the Federation of South African Societies of Pathology. Sun City. August 1993, p74.
77. The p53 tumour suppressor protein : expression and phosphorylation during cell differentiation. The 12th Congress of the S.A. Biochemical Society, Stellenbosch, January 1994, P137.
78. Protein kinase C and phosphotyrosine proteins in normal and leukaemic lymphocytes, The 12th Congress of the S.A. Biochemical Society, Stellenbosch. January 1994. P138.
79. Modulation of c-jun expression by phosphorylation. The 12th Congress of the S.A. Biochemical Society, Stellenbosch. January 1994. P139.
80. Platelet-derived growth factor and its receptor in human breast tissue. The 12th Congress of the S.A. Biochemical Society. Stellenbosch. January 1994, P140.
81. Subcellular distribution of protein kinase C in proliferating and differentiating murine erythroleukaemic cells. The 12th Congress of the S.A. Biochemical Society. Stellenbosch. January 1994, P146.
82. High frequency lactate dehydrogenase activity and differential isozyme dynamics in leukaemic cells. The 12th Congress of the S.A. Biochemical Society, Stellenbosch. January 1994. P147.
83. Tyrosine phosphorylation and the GAP protein in proliferating and differentiating cells. The 12th Congress of the S.A. Biochemical Society. Stellenbosch. January 1994. P148.
84. The p53 tumour suppressor protein : phosphorylation during cell differentiation. The 34th Annual Congress of the Federation of South African Societies of Pathology. Cape Town. July 1994.
85. Differentiation of HL-60 cells and the expression of phosphoprotein phosphatase 1/2A and protein tyrosine phosphatase-1B. The 34th Annual Congress of the Federation of South African Societies of Pathology. Cape Town. July 1994.
86. Phosphoprotein phosphatases in leukaemic cells. The 34th Annual Congress of the Federation of South African Societies of Pathology. Cape Town. July 1994.
87. Modulation of steroid hormone receptor binding by protein kinase activators: cellular response to glucocorticoids. The 34th Annual Congress of the Federation of South African Societies of Pathology. Cape Town. July 1994.
88. Platelet-derived growth factor (PDGF) and its receptors in human breast tissue. The 16th International Congress of Biochemistry and Molecular Biology. New Delhi, India. September 1994, P8-23.
89. Phosphoprotein phosphatases in human leukaemic cells. The 16th International Congress of Biochemistry and Molecular Biology. New Delhi, India. September 1994, P5-149.
90. Evidence for phosphoprotein phosphatases and the ras protein in human serum and erythrocytes. The 35th Annual Congress of the Federation of South African Societies of Pathology. Bloemfontein. July 1995.
91. Chemiluminescent detection of the p53 protein in murine erythroleukaemic cells. The 35th Annual Congress of the Federation of South African Societies of Pathology. Bloemfontein. July 1995.
92. Expression of the ras oncogene MRNA in proliferating and differentiating murine erythroleukaemic cells. The 35th Annual Congress of the Federation of South African Societies of Pathology. Bloemfontein. July 1995.
93. The effect of all trans retinoic acid on the expression of protein tyrosine phosphatase IB in HL60 cells. The 35th Annual Congress of the Federation of South African Societies of Pathology. Bloemfontein. July 1995.
94. Expression of phosphoprotein phosphatases in proliferating and differentiating cells. The First UK-RSA Symposium on Cell Growth Control. Cape Town. January 1996.
95. The expression of the ras oncogene and its protein product in proliferating and differentiating murine erythroleukaemic cells; temporal variations. The First UK-RSA Symposium on Cell Growth Control. Cape Town. January 1996.
96. Analysis of protein tyrosine phosphatase-IB messenger RNA and production of the recombinant protein. The 36th Annual Congress of the Federation of South African Societies of Pathology. Kruger Lodge. July 1996.
97. Protein phosphatases in erythroleukaemia cells. The 36th Annual Congress of the Federation of South African Societies of Pathology. Kruger Lodge. July 1996.
98. Protein phosphatases and reversal of transformation in murine erythroleukaemic cells. Cancer 97: Recent Advances in the Molecular and Cellular Aspects of Cancer. Langebaan, Cape. January 1997.
99. Expression of p53 and protein phosphatases in murine erythroleukaemic cells. The 37th Annual Congress of the Federation of South African Societies of Pathology. Cape Town. July 1997.
100. The role of protein kinase C in the progression of terminal differentiation of murine eyrthroleukaemic cells. The 37th Annual Congress of the Federation of South African Societies of Pathology. Cape Town. July 1997.
101. Protein tyrosine phosphatase in cancer cells. The 38th Annual Congress of the Federation of South African Societies of Pathology. Pretoria. June 1998.
102. Detection of proteins on polyacrylamide gels and nitrocellulose blots: a comparison of staining procedures. The 38th Annual Congress of the Federation of South African Societies of Pathology. Pretoria. June 1998.
103. Oscillations and cancer: control of protein kinases during proliferation and differentiation of leukaemic cells. Abstracts of the 17th International Cancer Congress. Rio de Janeiro, Brasil. August 1998.
104. Expression of the p53 protein in proliferating and differentiating murine erythroleukaemic cells. The Second FASBMB Meeting, Biochemistry for Africa. Potchefstroom, South Africa. September 1998.
105. Temporal variations in protein tyrosine phosphatase during cell proliferation and differentiation. The Second FASBMB, Biochemistry for Africa. Potchefstroom, South Africa. September 1998.
106. Evaluation of radiation damage by analysis of p53 tumour suppressor protein. The Second FASBMB Meeting, Biochemistry for Africa. Potchefstroom, South Africa. September 1998.
107. Cell dynamics and the regulation of protein tyrosine kinase activity in leukaemic cells. The 5th International Union of Biochemistry and Molecular Biology Conference on the Biochemistry of Health and Diseases. Jerusalem, Israel. October 1998.
108. Temporal variations in protein tyrosine phosphatase during cell proliferation and differentiation. The 1999 Miami Nature Biotechnology Winter Symposium. Miami, USA. February 1999.
109. Expression of the p53 tumour suppressor protein in proliferating and differentiating murine erythroleukaemic cells. The 1999 Miami Nature Biotechnology Winter Symposium. Miami. February 1999.
110. Modulation of phosphoprotein phosphatases in human leukaemia cells. Molecular and Cellular Networks. Proceedings of the 6th International Union of Biochemistry and Molecular Biology Conference. Seoul, Korea. October 1999.
111. Cell dynamics and the regulation of protein kinase activity in leukaemic cells. Third International Congress of the Federation of African Societies of Biochemistry and Molecular Biology. Cairo. November 2000.
112. Temporal organization in leukaemia cells: regulation of enzyme activity by phosphorylation. The 17th Meeting of the European Association for Cancer Research, Granada, Spain. June 2002. Oncologia, Vol 4 (Supp 1), 83.
113. Rhythmic patterns in the expression of phosphoproteins and protein phosphatases in human leukaemia cells. HGM 2003 Human Genome Meeting. Cancun, Mexico. April 2003. P95.
114. Rhythmic variations in expression of protein phosphatases in human leukaemia cells. The 43rd Conference of the Federation of South African Societies of Pathology. Johannesburg, South Africa. June 2003.
115. Tyrosine phosphorylation of proteins in leukaemia cells:expression profiles and cell dynamics. The 43rd Conference of the Federation of South African Societies of Pathology. Johannesburg, South Africa. June 2003.
116. Tyrosine kinase activity in leukaemia. The 43rd Conference of the Federation of South African Societies of Pathology. Johannesburg, South Africa. June 2003.
117. Apoptotic gene expression in elderly Emirati with neurodegenerative disease. The 5th Annual Research Conference, UAE University. Al Ain, UAE. April 2004.
118. Apoptosis signals in Alzheimer disease. The 29th Meeting of the Federation of European Biochemical Societies, Warsaw, Poland. June 2004. European J Biochem., Vol 271 (Supp 1), 221.
119. Protein tyrosine kinase activity in human leukaemia. The 18th Meeting of the European Association for Cancer Research, Innsbruck, Austria. July 2004.
120. The relationship between learning styles and the ability of preclinical medical students to predict their test results. The 4th GCC Medical Education Conference, A Ain, UAE. November 2004.
